1,664
Views
10
CrossRef citations to date
0
Altmetric
Short Communication

In vitro assessment of selected Korean plants for antioxidant and antiacetylcholinesterase activities

, , , , , , , & show all
Pages 2205-2210 | Received 05 Jun 2017, Accepted 13 Oct 2017, Published online: 08 Nov 2017

References

  • Adewusi EA, Moodley N, Steenkamp V. 2011. Antioxidant and acetylcholinesterase inhibitory activity of selected southern African medicinal plants. S Afr J Bot. 77:638–644.
  • Ali MY, Jung HA, Choi JS. 2015. Anti-diabetic and anti-Alzheimer’s disease activities of Angelica decursiva . Arch Pharm Res. 38:2216–2227.
  • Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T. 2007. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25-35. Behav Brain Res. 180:139–145.
  • Bae JR, Lee BD. 2015. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond. BMB Rep. 48:243–248.
  • Barre DE. 2001. Potential of evening primrose, borage, black currant, and fungal oils in human health. Ann Nutr Metab. 45:47–57.
  • Bartzokis G. 2004. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease. Neurobiol Aging. 25:5–18.
  • Budinčević M, Vrbaški Ž, Turkulovxyc J, Dimić E. 1995. Antioxidant activity of Oenothera biennis L. Fett Wiss Technol. Eur J Lipid Sci Tech. 97:277–280.
  • Corrigan FM, Horrobin DF, Skinner ER, Besson JAO, Cooper M. 1998. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer’s disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol. 30:197–207.
  • Dhanasekaran S, Perumal P, Palayan M. 2015. In-vitro screening for acetylcholinesterase enzyme inhibition potential and antioxidant activity of extracts of Ipomoea aquatic Forsk: therapeutic lead for Alzheimer’s disease. J App Pharm Sci. 5:12–16.
  • Eom HJ, Kang HR, Kim HK, Jung EB, Park HB, Kang KS, Kim KH. 2016. Bioactivity-guided isolation of antioxidant triterpenoids from Betula platyphylla var. japonica bark. Bioorg Chem. 66:97–101.
  • Gutzmann H, Hadler D. 1998. Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2-year double-blind multicentre study. J Neural Transm Suppl. 54:301–310.
  • Haque R, Nazir A. 2016. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: implications for Alzheimer’s disease. Biochim Biophys Acta. 1860:2454–2462.
  • Hung TM, Luan TC, Vinh BT, Cuong TD, Min BS. 2011. Labdane-type diterpenoids from Leonurus heterophyllus and their cholinesterase inhibitory activity. Phytother Res. 25:611–614.
  • Kapoor R, Huang Y-S. 2006. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol. 7:531–534.
  • Kim KH, Choi SU, Son MW, Choi SZ, Clardy J, Lee KR. 2013. Pharbinilic acid, an allogibberic acid from morning glory (Pharbitis nil). J Nat Prod. 76:1376–1379.
  • Kim KH, Choi SU, Lee KR. 2009. Diterpene glycosides from the seeds of Pharbitis nil. J Nat Prod. 7:1121–1127.
  • Kim KH, Choi SU, Son MW, Lee KR. 2010. Two new phenolic amides from the seeds of Pharbitis nil. Chem Pharm Bull. 58:1532–1535.
  • Kim KH, Ha SK, Choi SU, Kim SY, Lee KR. 2011. Bioactive phenolic constituents from the seeds of Pharbitis nil. Chem Pharm Bull. 59:1425–1429.
  • Kim KH, Jin MR, Choi SU, Son MW, Lee KR. 2008. Three new ent-kaurane diterpenoids from the seeds of Pharbitis nil. Heterocycles. 75:1447–1455.
  • Kim KH, Moon E, Lee SR, Park KJ, Kim SY, Choi SU, Lee KR. 2015. Chemical constituents of the seeds of Raphanus sativus and their biological activity. J Braz Chem Soc. 26:2307–2312.
  • Kim KH, Woo KW, Moon E, Choi SU, Kim SY, Choi SZ, Son MW, Lee KR. 2014. Identification of antitumor lignans from the seeds of morning glory (Pharbitis nil). J Agric Food Chem. 62:7746–7752.
  • Li N, Liu Y, Li W, Zhou L, Li Q, Wang X, He P. 2016. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer’s disease. J Ginseng Res. 40:9–17.
  • Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JPE, Butler LT. 2009. Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr. 4:227–242.
  • Mathew M, Subramanian S. 2014. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of Ayurvedic medicinal plants used for cognitive disorders. PLoS One. 9:e86804.
  • Mehta M, Adem A, Sabbagh M. 2012. New acetylcholinesterase inhibitors for Alzheimer’s disease. Int J Alzheimers Dis. 2012:728983
  • Moreno-Montoro M, Olalla-Herrera M, Rufián-Henares JÁ, Martínez RG, Miralles B, Bergillos T, Navarro-Alarcón M, Jauregi P. 2017. Antioxidant, ACE-inhibitory and antimicrobial activity of fermented goat milk: activity and physicochemical property relationship of the peptide components. Food Funct. 8:2783–2791.
  • Mukherjee PK, Kumar V, Mal M, Houghton PJ. 2007. Acetylcholinesterase inhibitors from plants. Phytomedicine. 14:289–300.
  • Nordin S, Monsch AU, Murphy C. 1995. Unawareness of smell loss in normal aging and Alzheimer’s disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol Psychol Sci. 50B:187–192.
  • Park YJ, Choi CI, Chung KH, Kim KH. 2016. Pharbilignan C induces apoptosis through a mitochondria-mediated intrinsic pathway in human breast cancer cells. Bioorg Med Chem Lett. 26:4645–4649.
  • Parodi J, Ormeño D, Ochoa-de la Paz LD. 2015. Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer’s disease study. BMB Rep. 48:13–18.
  • Roth A, Schaffner W, Hertel C. 1999. Phytoestrogen kaempferol (3,4’,5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity . J Neurosci Res. 57:399–404.
  • Sallam A, Mira A, Ashour A, Shimizu K. 2016. Acetylcholine esterase inhibitors and melanin synthesis inhibitors from Salvia officinalis. Phytomedicine. 23:1005–1011.
  • Schulz V. 2003. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider. Phytomedicine. 10:74–79.
  • Sim JY, Kim MA, Kim MJ, Chun WJ, Kwon YS. 2014. Acetylcholinesterase inhibitors from the stem of Zea mays. Nat Prod Sci. 20:13–16.
  • Škottová N, Kazdová L, Oliyarnyk O, Vecera R, Sobolová L, Ulrichová J. 2004. Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats. Pharmacol Res. 50:123–130.
  • Suh WS, Lee SR, Kim CS, Moon E, Kim SY, Choi SU, Kang KS, Lee KR, Kim KH. 2016. A new monoacylglycerol from the fruiting bodies of Gymnopilus spectabilis. J Chem Res (S). 40:156–159.
  • Sul D, Kim H-S, Lee D, Joo SS, Hwang KW, Park S-Y. 2009. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sci. 84:257–262.
  • Wang Q, Sun Y, Yang B, Wang Z, Liu Y, Cao Q, Sun X, Kuang H. 2014. Optimization of polysaccharides extraction from seeds of Pharbitis nil and its anti-oxidant activity. Carbohydr Polym. 102:460–466.
  • Wang Z-M, Cai P, Liu Q-H, Xu D-Q, Yang X-L, Wu J-J, Kong L-Y, Wang X-B. 2016. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease. Eur J Med Chem. 123:282–297.
  • Wettasinghe M, Shahidi F, Amarowicz R. 2002. Identification and quantification of low molecular weight phenolic antioxidants in seeds of evening primrose (Oenothera biennis L.). J Agric Food Chem. 50:1267–1271.
  • Wilcock GK, Lilienfeld S, Gaens E. 2000. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre randomized controlled trial. BMJ. 321:1–7.
  • Wu L, Tong T, Wan S, Yan T, Ren F, Bi K, Jia Y. 2017. Protective effects of puerarin against Aβ 1-42-Induced Learning and Memory Impairments in Mice . Planta Med. 83:224–231.
  • Xu T, Shen X, Yu H, Sun L, Lin W, Zhang C. 2016. Water-soluble ginseng oligosaccharides protect against scopolamine-induced cognitive impairment by functioning as an antineuroinflammatory agent. J Ginseng Res. 40:211–219.
  • Yehuda S, Rabinovtz S, Carasso RL, Mostofsky DI. 1996. Essential fatty acids preparation (Sr-3) improves Alzheimer’s patients quality of life. Int J Neurosci. 87:141–149.
  • Zee OP. 2009. Pharmacognosy. Seoul, Korea: Sunkyunkwan University Press.
  • Zhao Y, Dou J, Wu T, Aisa HA. 2013. Investigating the antioxidant and acetylcholinesterase inhibition activities of Gossypium herbaceam. Molecules. 18:951–962.